Investors
Welcome to Canatu’s investor pages!
Canatu is a nanotechnology scale-up company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, robotics, mobility and defence, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.
Gross margin, %
52.730.6.2026
Patents and patents pending
32230.6.2026
Employees
18230.6.2026
Interview with CEO Dr. Maximilian Slawinski
Canatu has already established its innovation leadership. Now, we’re sharpening our path to scalable growth. In this interview, our CEO tells our short- and long-term outlook, the evolution of the CNT pellicle market, and where Canatu stands competitively today.
Webcast: Canatu Half Year Financial Report 2026 & new strategy
In this presentation, our CEO Dr. Maximilian Slawinski and CFO Mikko Vesterinen present the H1 2026 results and the new strategy.
Canatu announces a leadership transition – Dr. Maximilian Slawinski appointed as CEO
Canatu announces a leadership transition by appointing Dr. Maximilian Slawinski as CEO and successor to Juha Kokkonen
Read more on our release.
Watch the Inderes interview of 11 May.
Latest investor presentation
The presentation covers Canatu’s strategy, business segments, technology, key strengths, and financials. See the latest investor presentation.
See related videos
Investor contacts
